| Literature DB >> 18274643 |
Efrat Broide1, Judith Sandbank, Eitan Scapa, Nimrod Alain Kimchi, Michael Shapiro, Aaron Lerner.
Abstract
Lymphocytic gastritis (LG) is associated with helicobacter pylori (Hp) and celiac disease (CD). We aimed to clarify the relationship between Hp infection and CD by defining a unique histopathology profile of LG in these two diseases. Forty patients who underwent upper endoscopy were divided into four groups: eight controls, ten active CD patients without Hp, twelve CD negative with Hp, and ten active CD with Hp infection. Antral samples were assessed by immunohistochemical staining for CD20, CD3, CD4, CD8, CD57, CNA42, and Ki67 for lymphoid aggregates, intraepithelial lymphocytes (IELs) number, density of lamina propria (LP) lymphocytes, and inflammatory glandular involvement. Only IELs positive for CD3 and CD8 were increased significantly in CD patients with or without Hp infection. Hp did not contribute to the number of CD8 IELs. In complicated cases with Hp and suspicious for CD, the number of CD8+ IELs hints toward a CD rather than Hp infection.Entities:
Mesh:
Year: 2007 PMID: 18274643 PMCID: PMC2222270 DOI: 10.1155/2007/81838
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Demographic data.
| Group | Mean age ± SD yrs (range) | Male/female | Total no. |
|---|---|---|---|
| Controls |
| 2/6 | 8 |
| CD+/Hp- |
| 1/9 | 10 |
| CD-/Hp+ |
| 3/9 | 12 |
| CD+/Hp+ |
| 2/8 | 10 |
|
| NS | NS |
Antibodies used for immunohistochemical evaluation.
| Ab | Source | Clone no | Ag retrieval | Dilution |
|---|---|---|---|---|
| CD3 | DAKO | Polyclonal | Citrate buffer | 1:50 |
| CD20 | DAKO | L26 | Citrate buffer | 1:400 |
| CD4 | Zymed | ZT-17 | Citrate buffer | None |
| CD8 | DAKO | C8/144B | Citrate buffer | 1:40 |
| CD57 | Novocastra | NK-1 | Citrate buffer | 1:50 |
| Ki67 | DAKO | MIB-1 | Citrate buffer | 1:200 |
| CNA42 | DAKO | CNA42 | Citrate buffer | 1:75 |
Lymphoid aggregates in antrum.
| Significance between groups | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Group 1 controls | Group 2 CD+/Hp- | Group 3 CD-/Hp+ | Group 4 CD+/Hp+ | [1-2] | P[1–3] | P[1–4] | P[2-3] | P[2–4] | P[3-4] | |
| Mean no. | 0.125 | 0.900 | 3.75 | 2 | ||||||
| SD | 0.354 | 0.738 | 2.417 | 1.764 | NS |
| NS |
| NS | NS |
| Minimum | 0 | 0 | 0 | 0 | ||||||
| Maximum | 1 | 2 | 7 | 5 | ||||||
Mean intraepithelial lymphocytes number (immunohistochemistry staining).
| Significance between groups | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Imunohistochemical staining | Group 1 controls | Group 2 CD+/Hp- | Group 3 CD-/Hp+ | Group 4 CD+/Hp+ | [1-2] | P[1–3] | P[1–4] | P[2-3] | P[2–4] | P[3-4] |
| CD3 [mean ± SD] | 1 |
|
|
|
| NS |
| NS | NS |
|
| CD8 | 0 |
|
|
|
| NS |
|
| NS |
|
| Ki67 | 0 |
| 0 |
| NS | NS | NS | NS | NS | NS |
Figure 1Immunohistochemical staining for CD3, CD4, and CD8 in the four different groups. Controls: (a)-CD3, (b)-CD4, (c)-CD8 (all o.mX200); Hp+/CD-: (d)-CD3 (o.mX400), (e)-CD4 (o.mX200), (f)-CD8 (o.mX200); Hp-/CD+: (g)-CD3 (o.mX200), (h)-CD4 (o.mX400), (i)-CD8 (o.mX400); Hp+/CD+: (j)-CD3, (k)-CD4, (l)-CD8 (all o.mX200).